Insiders · Profile

Jaksch Frank L Jr

Director at Niagen Bioscience. Filing since 8 Dec 2010. CIK 0001437237

Company
Date
Role
Action
Shares
Amount
Of holding
13 Dec 2024
Director
Sold at will
37,161
$229.96K
13.2%
12 Jun 2023
Director
Bought
7,000
$11.83K
3.1%
10 Dec 2020
EXECUTIVE CHAIRMAN OF BOARD
Sold, plan not stated
37,829
$196.33K
14.4%
11 Mar 2019
EXECUTIVE CHAIRMAN OF BOARD
Sold, plan not stated
14,390
$50.37K
6.1%
16 May 2018
CEO
Bought
4,300
$15.31K
2.1%
15 May 2018
CEO
Bought
5,500
$19.86K
2.7%
29 Mar 2018
CEO
Sold, plan not stated
474
$2.18K
0.2%
27 Mar 2018
CEO
Sold, plan not stated
24,578
$113.06K
10.9%
11 Jan 2018
CEO
Sold, plan not stated
6,249
$40.62K
3.0%
10 Jan 2018
CEO
Sold, plan not stated
22,130
$144.29K
9.9%
21 Dec 2017
CEO
Sold, plan not stated
58,400
$361.50K
22.5%
12 Dec 2016
CEO, PRESIDENT
Bought
2,000
$4.84K
1.0%
1 Sep 2016
CEO, PRESIDENT
Bought
1,500
$4.98K
0.8%
22 Aug 2014
CEO, PRESIDENT
Bought
5,000
$5.80K
0.8%
13 Jun 2012
CEO, PRESIDENT
Bought
5,000
$3.60K
5.9%
16 May 2012
CSO
Bought
5,000
$2.70K
6.3%
10 Feb 2012
CSO
Bought
66,665
$50.00K
533%
7 Dec 2011
CEO
Bought
7,500
$4.50K
150%
8 Dec 2010
CEO
Bought
5,000
$7.50K
opened
19 decisions on file.